USP Grade Oncology Drug CAS 19767-45-4 Mesna

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Mesna
• Mf: C2h5nao3s2
• MW: 164.1791
• Type: Antineoplastic Agents
• Storage: Cool Dry Place
• Shelf Life: 24 Months
• Transport Package: 1kg/Bag, 25kg/Drum
• Specification: Mesna
• Trademark: HNB
• Origin: China
• Production Capacity: 500kg/Month

Product Description

Mesna	CAS : 19767-45-4	Brand:HNB
	MW: C2H5NaO3S2	MSDS: Avaiable
	MF : 164.17	Sample: Avaiable
	Category: Oncology drug	Min order: 10grams
	Quality standard:   USP	Place of Origin:China
Introduction	Mesna is an organosulfur compound. It is used in cancer chemotherapy involving cyclophosphamide and ifosfamide as an adjuvant. It is an acronym for 2-Mercaptoethane sulfonate Na (Na being the symbol for sodium). Mesna is used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy. These two anticancer agents, in vivo, may be converted to urotoxic metabolites such as acrolein. It assists to detoxify these metabolites by reaction of its sulfhydryl group with the vinyl group. It also increases urinary excretion of cysteine
Character	White to off-white powder
Applications	Pharmaceutical raw materials , Oncology drug

 

Indication:

Prevent urinary tract toxicity caused by cyclophosphamide, different cyclophosphamide, chlorine phosphorus amide medicines
Pharmacology:

This product is contained half glutathione amino acid compounds, can repeat activation cyclophosphamide with toxic or the daughter cyclophosphamide metabolites unifies, forming non toxic product which quickly out of body with urine. 
Prevent urinary tract toxicity caused by cyclophosphamide, different cyclophosphamide, chlorine phosphorus amide medicines